(Q42240063)

19 October 2017

title

Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City (English)

1 reference

19 October 2017

1 reference

1 reference

Kara A Livingston

1

1 reference

19 October 2017

Jennifer B Rosen

series ordinal

2

1 reference

19 October 2017

Jane R Zucker

series ordinal

3

1 reference

19 October 2017

Christopher M Zimmerman

series ordinal

4

1 reference

19 October 2017

language of work or name

English

0 references

publication date

16 November 2013

1 reference

19 October 2017

1 reference

19 October 2017

volume

32

1 reference

19 October 2017

issue

3

1 reference

19 October 2017

page(s)

369-374

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

19 October 2017

1 reference

Recent resurgence of mumps in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Mumps resurgences in the United States: A historical perspective on unexpected elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Non-preventable mumps outbreaks in schoolchildren in Catalonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Effectiveness of Jeryl Lynn-containing vaccine in Spanish children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Sub-optimal prevalence of mumps antibodies in a population based study of young adults in Israel after 20 years of two dose universal vaccination policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Mumps outbreak in Orthodox Jewish communities in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Benefits and barriers to electronic laboratory results reporting for notifiable diseases: the New York City Department of Health and Mental Hygiene experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Using an immunization information system to improve accountability for vaccines distributed through the Vaccines for Children program in New York City, 2005-2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Mumps in a northeast metropolitan community. I. Epidemiology of clinical mumps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Live, attenuated mumps-virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students--Iowa, 2006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

The effectiveness of the mumps component of the MMR vaccine: a case control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Effectiveness of previous mumps vaccination during a summer camp outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Mumps vaccine effectiveness in highly immunized populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Mumps vaccine performance among university students during a mumps outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Vaccination and herd immunity to infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.11.021

10.1016/J.VACCINE.2013.11.021

7 January 2021

Identifiers

DOI

1 reference

release_f37djo6t5rghjk7btzuju7yh5m

19 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f37djo6t5rghjk7btzuju7yh5m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference